Advertisement

Picture Berlin Partner Top News Amboss Secures EUR240m Funding 650x100px
All > Germany >

Deals > Northern Germany

Find below deals from the Northern German Federal States of Bremen (HB), Hamburg (HH), Mecklenburg-Vorpommern (MVP), Niedersachsen (NS) and Schleswig-Holstein (SWH). Listed are deals for this region as well as from organisations located there.

Total search results: 310 | Ordered by Date (descending)
1 2 3 4  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Bico–Sartorius: investment, 202404– acquisition 100% of MatTek Corp + Visikol Inc on cash/debt-free basis for $80m by Sartorius Lab Holding GmbH 2025-04-04
GQ Bio Therapeutics–Pacira: investment, 202502 acquisition remaining 81% in GQ Bio for $32m by Pacira 2025-02-27
Phaeosynt–Fonde Ventures: investment, 202502 seed financing round totalling €1.7m incl new investor Fonde Ventures 2025-02-12
Phaeosynt–Lower Saxony (govt): investment, 202502 seed financing round totalling €1.7m incl new investor NBank Capital Beteiligungsgesellschaft mbH 2025-02-12
Phaeosynt–OTHER: investment, 202502 seed financing round totalling €1.7m incl existing investors 2025-02-12
Phaeosynt–PERSON: investment, 202502 seed financing round totalling €1.7m incl new investor Thomas Tönnesmann 2025-02-12
Phaeosynt–PERSON: investment, 202502 seed financing round totalling €1.7m incl new investor Ulrich Gehrke 2025-02-12
Phaeosynt–PSD Bank: investment, 202502 seed financing round totalling €1.7m incl new investor PSD Braunscheig Verwaltungs-GmbH 2025-02-12
Phaeosynt–Renditei: investment, 202502 seed financing round totalling €1.7m incl new investor Renditei UG 2025-02-12
Phaeosynt–SEVERAL: investment, 202502 seed financing round €1.7m from existing + new investors 2025-02-12
Phaeosynt–TrueNorth Ventures: investment, 202502 seed financing round totalling €1.7m incl new investor TrueNorth Ventures UG 2025-02-12
IBA Lifesciences–Cube Biotech: investment, 202501 acquisition of IBA Lifesciences by Cube Biotech backed by majority owner Archimed 2025-01-13
Evotec–Halozyme: investment, 202411 acquisition €2b unsolicited + non-binding cash offer at €11/share refused + withdrawn NOT REALISED 2024-11-14
Centogene–Charme Capital Partners: investment, 202411–202503 acquisition €8.7m of sole operating subsidiary Centogene GmbH by Charme Capital 2024-11-13
Yumab–Molcure: AI-based drug discovery, 202410– collab expansion to incl zero-shot AI Ab discovery technology to discover Abs for undrugged targets 2024-10-08
Dynamic Biosensors–Bruker: investment, 202410 acquisition €na of Dynamic Biosensors GmbH + integration in Bruker Biosensors business 2024-10-02
Novo Group–Evotec: cell therapy manufacturing, 202409– collab technology development €na RnD funding + upfront + milestone payments plus royalties 2024-09-26
Lucid Genomics–BIF Partners: investment, 202408 pre-seed financing round totalling €1.3m incl co-investor BIF Partners 2024-09-02
Allogenetics–Carma Fund: investment, 202408 first financing round totalling €3.4m incl co-lead investor Carma Fund 2024-08-29
Allogenetics–Lower Saxony (govt): investment, 202408 first financing round totalling €3.4m incl co-lead investor NBank Capital 2024-08-29
Allogenetics–OTHER: investment, 202408 first financing round totalling €3.4m incl several business angels 2024-08-29
Allogenetics–SEVERAL: investment, 202408 first financing round €3.4m led by NBank Capital + Carma Fund 2024-08-29
mzio–Bremen (govt): grant, 202408 grant funding €150k from BAB co-funded by EU 2024-08-21
Lignopure–Lower Saxony (govt): investment, 202407 equity financing round totalling €2.4m incl lead investor NBank Capital 2024-07-17
Lignopure–NiedersachsenMetall: investment, 202407 equity financing round totalling €2.4m incl co-investor Niedersachsen Beteiligungs GmbH & Co KG 2024-07-17
Lignopure–OTHER: investment, 202407 equity financing round totalling €2.4m incl existing investors 2024-07-17
Lignopure–OTHER: investment, 202407 equity financing round totalling €2.4m incl a Family Office as co-investor 2024-07-17
Lignopure–RaakWark Kaptaal: investment, 202407 equity financing round totalling €2.4m incl co-investor RaakWark Kaptaal 2024-07-17
Lignopure–SEVERAL: investment, 202407 equity financing round €2.4m led by NBank Capital 2024-07-17
Carelane–High-Tech Gründerfonds: investment, 202406 pre-seed financing round totalling €800k incl lead investor HTGF 2024-06-20
Carelane–SEVERAL: investment, 202406 pre-seed financing round €800k led by HTGF 2024-06-20
Mondi–Traceless Materials: biomaterials, 202406– collab strategic partnership using traceless material for paper coating solutions 2024-06-18
PINK gegen Brustkrebs–Sidekick Health: investment, 202406 acquisition of PINK! by Sidekick Health 2024-06-18
ITM–Carbyne Equity Partners: investment, 202406 financing round totalling €188m incl exisitng + co-investor Carbyne Equity Partners 2024-06-06
Evotec–Qiagen: bioinformatics, 202406– collab integration of OmicSoft Land Databases with PanHunter platform for partners + clients 2024-06-03
Sartorius–Nvidia: AI-based drug discovery + manufacturing, 202405– collab expansion incl adaption of Nvidia Clara Suite + DGX platform 2024-05-16
Sartorius–Sanofi: biopharmaceutical production technology, 202405– collab + license developm of ICB platform to be excl commercialised by Sartorius ww 2024-05-13
Topas Therapeutics–Trophic Communications: public relations, 202405 service existent by Trophic 2024-05-01
Bayer–Evotec: drug discovery services, 202404– update to strategic collab €na with new focus on precision cardiology usinsg iPSCs 2024-04-30
Cultimate Foods–Life Science Valley: investment, 202404 seed financing round totalling €2.3m incl co-investor LSV Wachstumsfonds 2024-04-23
Innocent Meat–Mecklenburg-Vorpommern (govt): investment, 202403 financing round totalling €3m incl €500k from existing investor VC Fonds MV 2024-03-26
Innocent Meat–OTHER: investment, 202403 financing round totalling €3m incl €2.5m from a new private investor 2024-03-26
Innocent Meat–SEVERAL: investment, 202403 financing round €3m with Venture Capital Fonds MV + new private investor 2024-03-26
Protembis–SEVERAL: investment, –202403 financing round Series B €30m completed in two separate capital increases 2024-03-26
Cardior Pharmaceuticals–Novo Group: investment, 202403– acquisition for up to €1.025b incl upfront payment + milestones ANNOUNCED 2024-03-25
Tubulis–Evotec: investment, 202403 financing round Series B2 totalling €128m incl existing + co-investor Evotec 2024-03-14
HiDocTechnologies–Mahana Therapeutics: investment, 202403 acquisition €na of Cara Care by Mahana Therapeutics 2024-03-12
Cellbox Solutions–EU (govt): investment, 2024– equity investment up to €10m from EIC Accelerator 2024-01-01
Aidhere–Sidekick Health: investment, 202310 acquisition of Aidhere out of bankrupcty by Sidekick Health 2023-10-10
Traceless Materials–b.value: investment, 202309 financing round Series A totalling €36.6m incl existing + co-investor b.value 2023-09-25
Traceless Materials–GLS Bank: investment, 202309 financing round Series A totalling €36.6m incl new + co-investor GLS Bank Hamburg 2023-09-25
Traceless Materials–High-Tech Gründerfonds: investment, 202309 financing round Series A totalling €36.6m incl existing + co-investor HTGF 2023-09-25
Traceless Materials–Planet A: investment, 202309 financing round Series A totalling €36.6m incl existing + co-investor Planet A Ventures 2023-09-25
Traceless Materials–SEVERAL: investment, 202309 financing round Series A €36.6m led by UB FIGG plus other new + all existing investors 2023-09-25
Traceless Materials–Sparkassen (DE): investment, 202309 financing round Series A totalling €36.6m incl new + co-investor HaSpa 2023-09-25
Traceless Materials–SWEN Capital Partners: investment, 202309 financing round Series A totalling €36.6m incl new + co-lead investor Blue Ocean fund 2023-09-25
Traceless Materials–United Bankers: investment, 202309 financing round Series A totalling €36.6m incl new + lead investor UB FIGG 2023-09-25
CrystalsFirst–Helmholtz: drug discovery technology, 202309–202410 collab developm in joint project LigandML with DESY with funding from IFB Hamburg 2023-09-01
Takara Shuzo–Eppendorf: lab automation equipment, 202308– collab strategic co-marketing agreem automating Takara Bio chemistries on epMotion platforms 2023-08-25
Cellbox Solutions–EU (govt): grant, 202308–202507 EIC Accelerator grant €2.5m 2023-08-01
Cellbox Solutions–Akampion: public relations, 202307 service existent by Akampion 2023-07-05
ITM–Carbyne Equity Partners: investment, 202306 financing round totalling €255m incl new + co-investor Carbyne Equity Partners 2023-06-05
Sartorius–Waters: biopharma production technology, 202306– collab expansion integration of PATROL UPLC PAS with Resolute BioSMB platform 2023-06-05
Traceless Materials–Germany (govt): grant, 202305– BMUV funding €5.1m for construction of demonstration plant 2023-05-19
BMS–Evotec: drug discovery services, 202303–203102 strategic RnD collab expansion 8 years $50m upfront + total potential $4b neurodegenerative drugs 2023-03-28
Cellbox Solutions–SEVERAL: investment, 202303 financing round Series A1 €6.5m led by CK Ventures 2023-03-07
Calibre Scientific–Eppendorf: micromanipulation products, 202303 acquisition of micromanipulation product portfolio of Eppendorf by Calibre Scientific 2023-03-06
Akttya Therapeutics–CrystalsFirst: drug discovery services, 202302– supply service €na using SmartSoak technology on novel protein targets of Akttyva 2023-02-23
Life Science Valley–Lower Saxony (govt): investment, 202302 fund launch with total of €12m incl €6m from NBank 2023-02-13
Life Science Valley–Sartorius: investment, 202302 fund launch with total of €12m incl €6m from Sartorius + Univ Medical Center Göttingen combined 2023-02-13
Life Science Valley–SEVERAL: investment, 202302 fund launch with €12m incl €6m from Niedersachsen + remainder from Sartorius + Univ Göttingen 2023-02-13
Life Science Valley–Univ Göttingen: investment, 202302 fund launch with total of €12m incl €6m from Univ Medical Center Göttingen + Sartorius combined 2023-02-13
JnJ–Evotec: cancer immunotherapy, 202301– strategic collab + license agreem developm first-in-class targeted immune-based cancer therapies 2023-01-26
Biognosys–Bruker: investment, 202301 acquisition $73.6m of majority share in Biognosys by Bruker 2023-01-04
S-Biomedic–Beiersdorf: investment, 202212 acquisition €na of majority share in S-Biomedic NV by Beiersdorf AG 2022-12-16
Bico–Sartorius: investment, 202212– directed share issue SEK487m (€45m) to existing investor Sartorius resulting 10.1% share + 8.5% of voting rights 2022-12-08
Sartorius–Bico: laboratory equipment, 202212– collab RnD 3D cell printing technologies + digital soluitons for cell line development workflows 2022-12-08
Sartorius–Bico: laboratory equipment, 202212– distribution of Bico products in APAC region by Sartorius 2022-12-08
Cajal Neuroscience–Evotec: investment, 202211 financing round Series A totalling $96m incl existing + co-investor Evotec 2022-11-29
Sartorius–SEVERAL: credit, 202211– placement of total of €650m Schulschein loans with 3, 5, 7, 10 + 13 years maturity 2022-11-11
Centogene–BC Platforms: data integration and analysis s/w, 202211– collab Centogene launches Biodata Network on BCRQUEST.com of BC Platforms 2022-11-03
Evotec–MHH: biospecimen, 202210– collab access to SjS + SLE patient biospecimen for analysis with PanOmics platform to expand E.MPD database 2022-10-25
Evotec–Adapsyn Biotechnology: drug discovery, 202209– strategic collab €na providing Evotec with access to drug-like small molecules for screening 2022-09-21
Indivumed–CellPhenomics: drug target research, 202209– collab to develop platform for cancer drug target discovery + validation 2022-09-07
Central Glass–Evotec: investment, 202208–202211 acquisition of Central Glass Germany GmbH for € 1 by Evotec 2022-08-25
ChemDiv–Schaffhausen Institute of Technology: drug discovery, 202208– collab strategic establishment of dedicated research group at Jacobs Univ 2022-08-11
Trace Analytics–908 Devices: investment, 202208 acquisition $15.3m upfront cash + $2m cash milestones 2022-08-09
Corat Therapeutics–Germany (govt): grant, 202207– up to €38.7m funding from BMBF for pivotal trial of Covid-19 drug candidate COR-101 2022-07-13
Boehringer–Evotec: investment, 202207 launch of €40m joint venture Aurobac incl €5m from co-investor Evotec 2022-07-06
Life Science Valley–Lower Saxony (govt): grant, 202207–202412 project grant funding €5m with €2m for business incubator + €3m directly for start-ups 2022-07-01
Molzym–OTHER: investment, 202206 investment 2-digit €m from large single family office 2022-06-29
Carma Fund–Evotec: investment, 202206 first closing totalling €47m of Carma Fund I incl investor Evotec SE 2022-06-21
Ymmunobio–Yumab: cancer antibody drug, 202206– collab €na optimisation of CEACAM antibodies by Yumab 2022-06-16
JnJ–Evotec: drug discovery services, 202206– collab discover novel mode of action drugs using TargetAlloMod platforms for Janssen Pharmaceutica 2022-06-14
Rigenerand–Evotec: investment, 202205–202207 acquisition 100% for €23m 2022-05-30
Almirall–Evotec: drug discovery services, 202205– collab multi-target RnD alliance in medical dermatology 2022-05-19
HH2E–Foresight Group: investment, 202205 financing round totalling at least €12m incl Foresight Group acquiring minority share 2022-05-16
HH2E–HydrogenOne Capital: investment, 202205 financing round totalling at least €12m incl HydrogenOne Capital acquiring minority share 2022-05-16
HH2E–SEVERAL: investment, 202205 financing round at least €12m with HydrogenOne Capital + Foresight Group aquiring minoirty stakes ANNOUNCED 2022-05-16
Tubulis–Evotec: investment, 202205 financing round Series B totalling €60m incl new + co-investor Evotec 2022-05-03
1 2 3 4  next pagenext page



Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Swiss Biotech Association LSG Global Village 2025 Basel 650x300px

» top